[m6A RNA methylation is a potential biological target for neuropathic pain].

Abstract

N6-methyladenosine (m⁶A) is the most common type of RNA modification in eukaryotes, which affects intracellular RNA metabolism and controls gene expression of related pathophysiological processes through dynamic reversible regulation of methyltransferases, demethylases and m⁶A-binding proteins. In recent years, the involvement of m⁶A methylation in the study of neuropathic pain has become a hot topic, some new understandings have been emerging, and m⁶A methylation has become a potential biological target for the treatment of neuropathic pain. Therefore, this article reviews the role and regulation of m⁶A methylation in neuropathic pain, in order to provide new enlightenment for the drug development and treatment of neuropathic pain.